eSonics Group

Esonics Group is a professional company engaged in the research, development, and manufacturing of inhalation drug delivery devices and systems, with its headquarters located in Shanghai. The group's product portfolio is comprehensive, covering aerosol inhalation drug delivery systems and components, dry powder inhalation systems, soft mist inhalation systems, nasal drug delivery systems, and more. In addition, the group is also conducting research and development in forward-looking areas such as smart inhalation devices and other advanced drug delivery technologies, aiming to establish a full-category platform for oral and nasal inhalation drug delivery systems. Esonics Group owns subsidiaries such as eSonics, PharmaCan, and InhalerTech, each responsible for different business segments. Among them, PharmaCan is a global leader in the manufacturing of pMDI canisters and actuators, capable of designing, developing, and manufacturing a full range of pMDI canisters in various sizes, including aluminum plain cans, stainless steel cans, FEP-coated cans, and anodized cans, which are compatible with various pMDI valves, actuators, and drug formulations. Esonics Group boasts a strong R&D team and has obtained and applied for over 70 patents. With years of collaborative growth with customers in the pharmaceutical and medical device industries at home and abroad, the group has accumulated profound technical expertise and practical experience. It continues to promote technological innovation and product development, striving to provide customers with safer, more efficient, and convenient inhalation drug delivery system solutions. Esonics Group has two production bases in Shanghai and Ningbo, focusing on establishing a strict quality management system and equipping with advanced production equipment to ensure product quality and stability. Looking forward, eSonics Group will continue to uphold the corporate spirit of "focus, innovation, and excellence." It is committed to continuously advancing technological innovation and market expansion, providing customers with higher-quality inhalation drug delivery products and services, and aspiring to become a leading enterprise in the global field of inhalation drug delivery.